Gadolinium-based MRI contrast agents induce mitochondrial toxicity and cell death in human neurons, and toxicity increases with reduced kinetic stability of the agent

DV Bower, JK Richter, H von Tengg-Kobligk… - Investigative …, 2019 - journals.lww.com
Objectives This preclinical study was devised to investigate potential cellular toxicity in
human neurons induced by gadolinium-based contrast agents (GBCAs) used for contrast …

Intracranial gadolinium deposition after contrast-enhanced MR imaging

RJ McDonald, JS McDonald, DF Kallmes, ME Jentoft… - Radiology, 2015 - pubs.rsna.org
Purpose To determine if repeated intravenous exposures to gadolinium-based contrast
agents (GBCAs) are associated with neuronal tissue deposition. Materials and Methods In …

Impaired mitochondrial function and oxidative stress in rat cortical neurons: implications for gadolinium-induced neurotoxicity

X Feng, Q Xia, L Yuan, X Yang, K Wang - Neurotoxicology, 2010 - Elsevier
Gadolinium (Gd), a rare-earth lanthanides metal, is widely utilized for various industrial and
medical purposes, particularly in brain magnetic resonance imaging. However, its potential …

Neurologic effects of gadolinium retention in the brain after gadolinium-based contrast agent administration

J Ayers-Ringler, JS McDonald, MA Connors, CR Fisher… - Radiology, 2022 - pubs.rsna.org
Background Concerns over the neurotoxic potential of retained gadolinium in brain tissues
after intravenous gadolinium-based contrast agent (GBCA) administration have led to …

Exposure to gadolinium and neurotoxicity: current status of preclinical and clinical studies

CA Mallio, À Rovira, PM Parizel, CC Quattrocchi - Neuroradiology, 2020 - Springer
Purpose Gadolinium is a rare-earth lanthanide metal that is known to have a direct
neurotoxic effect. The scope of the present review is to summarize the current preclinical and …

[HTML][HTML] The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity-A systematic review

C Olchowy, K Cebulski, M Łasecki, R Chaber… - PloS one, 2017 - journals.plos.org
Background and purpose Gadolinium based contrast agents (GBCAs) are widely used in
magnetic resonance imaging, but recently, high signal intensity in the cerebellum structures …

Gadolinium deposition in human brain tissues after contrast-enhanced MR imaging in adult patients without intracranial abnormalities

RJ McDonald, JS McDonald, DF Kallmes, ME Jentoft… - Radiology, 2017 - pubs.rsna.org
Purpose To determine whether gadolinium deposits in neural tissues of patients with
intracranial abnormalities following intravenous gadolinium-based contrast agent (GBCA) …

Long-term excretion of gadolinium-based contrast agents: linear versus macrocyclic agents in an experimental rat model

G Jost, T Frenzel, J Boyken, J Lohrke, V Nischwitz… - Radiology, 2019 - pubs.rsna.org
Purpose To investigate the long-term course of MRI signal intensity (SI) changes and the
presence of gadolinium in the rat brain during a 1-year period after multiple administrations …

[HTML][HTML] Linear gadolinium-based contrast agents are associated with brain gadolinium retention in healthy rats

P Robert, X Violas, S Grand, S Lehericy… - Investigative …, 2016 - journals.lww.com
Objectives The aim of this study was to evaluate Gd retention in the deep cerebellar nuclei
(DCN) of linear gadolinium-based contrast agents (GBCAs) compared with a macrocyclic …

Safety of the gadolinium-based contrast agents for magnetic resonance imaging, focusing in part on their accumulation in the brain and especially the dentate nucleus

VM Runge - Investigative radiology, 2016 - journals.lww.com
The established class of intravenous contrast media for magnetic resonance imaging is the
gadolinium chelates, more generally referred to as the gadolinium-based contrast agents …